Clinical Trial Update: Ruxolitinib Combined With Dexamethasone for HLH [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating ruxolitinib in combination with dexamethasone for Hemophagocytic Lymphohistiocytosis (Phase 1/Phase 2) has placeholder status with n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Capital Research Institute of Pediatrics | Conditions: Hemophagocytic Lymphohistiocytosis | Phase 1, Phase 2 | Status: UNKNOWN